Email updates

Keep up to date with the latest news and content from BMC Microbiology and BioMed Central.

Open Access Correction

Correction: Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand

Jirarut Jonmalung1, Therdsak Prammananan24, Manoon Leechawengwongs34 and Angkana Chaiprasert14*

Author Affiliations

1 Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand

2 National Center for Genetic Engineering and Biotechnology, National Science and Technology, Development Agency, Ministry of Science and Technology, Pathumthani 12120, Thailand

3 Vichaiyut Hospital, Setsiri Road, Bangkok 10400, Thailand

4 Drug-Resistant Tuberculosis Research Fund, Siriraj Foundation, Bangkok 10700, Thailand

For all author emails, please log on.

BMC Microbiology 2010, 10:278  doi:10.1186/1471-2180-10-278

Published: 9 November 2010

First paragraph (this article has no abstract)

After galley proof of the manuscript, we found three mistakes of the nucleotide positions (G222C, G364A and C520T) and codon numbers (Gly74Arg, Gly122Ser and Thr174Ile) that have to be corrected but it was unable to make any change because the publication of this work is on going [1]. After revision, Table two (Table 1 in this manuscript) and some information in the discussion part were changed. There were only 5 novel mutation types found in this study, consisting of 2 nucleotide substitutions (Leu27Pro and Thr174Ile), 2 nucleotide insertions (G insertion between nucleotide 411 and 412 and GG insertion between nucleotide 520 and 521), and 1 nonsense mutation at Glu127.